Release Notes | MyRBQM® Portal Version 6.1.0
MyRBQM Portal V6.1.0 released! We're constantly working to improve your Risk-Based Quality Management experience. Download the summary of what has changed.
Oct
2020
Sep
2020
FDA Concerned About Statistical Power COVID-19 Impacted Clinical Studies
Checking and maintaining trial integrity, and proactively adjusting trial analysis strategies to ensure trial data validity, are the FDA's two key areas of concern.
Aug
2020
Risk-based Monitoring Software Key Players Influencing the Market
The report provides key statistics on the market status of the leading Risk-based Monitoring (RBM) Software market players and offers key trends and opportunities in the market.
May
2020
AI-Enhanced Machine Learning Predictions for All Clinical Research Metrics
MyRBQM® Portal's new Machine Learning predictive analytics model is far less sensitive to noise, it better generalizes data, and provides narrower CIs in long time series. Singular Spectrum Analysis is particularly valuable for long time series, as mostly observed in clinical trials.
Apr
2020
Q&A | Minds-On Impact COVID-19 on Clinical Trials
We've created this "ask the experts" Q&A to provide clear responses to the questions that were most often asked by the forum's participants.
Mar
2020
Cyntegrity Amongst Companies Fighting Back the COVID-19 Outbreak
Frontiers Health Ecosystem Companies Fighting Back the COVID-19 Outbreak As the COVID-19 outbreak continues, it has become even more challenging for patients to seek in- person medical care and for healthcare providers (HCP) to guarantee community health services for people who may have symptoms [...]
Mar
2020
Coronavirus | COVID-19 RACT Now Available
Cyntegrity developed a special COVID-19 RACT that guides those involved in clinical trials on specific risks which may arise as a result of COVID-19, and how they can mitigate them. This special RACT is part of the COVID-19 rapid deployment pack for ad-hoc centralized monitoring.
Mar
2020
Coronavirus | What if you can no longer visit your sites?
We can help establish near real-time centralized monitoring, enable the use of "ad-hoc crisis management" Key Risk Indicators (KRIs), and mitigate patient safety and study quality risks.
Mar
2020
Best Case Studies for RBQM | Merz Pharma’s RBQM Journey
This week Applied Clinical Trials published an interesting case study of the risk-based quality management learning curve. The provision of a set of training modules helped Merz Pharma to initiate a smooth RBQM rollout.
Feb
2020
Indication Focused RBQM for Rare Disease Drug Development
Adaptive and intelligent Risk Based Quality Management (RBQM) is a powerful strategy for rare disease research. One of the main benefits is that RBQM allows for patient-centric trial design that is uniquely tailored to the specific rare disease.